ORR was 50% in patients treated with MDNA11 in 2L/3L setting and 42% when MDNA11 was the next treatment post-ICI failure, ...

Abu Dhabi, UAE: IHC, a global investment company focused on building dynamic value networks, today announced a strategic ...

The NEO-CYT study, sponsored by Fondazione Melanoma Onlus, will be evaluating MDNA11 in front-line therapy for resectable ...

Aims to Build on Positive 2025 Interim TN-201 Results in First Half of 2026 with Longer-Term Follow-Up Data for Cohorts 1 and 2 from MyPEAK™-1 ...

Critical Metals Corp. ( CRML) is on a rollercoaster ride. Since rumors surfaced that the U.S. would take an equity stake in ...

Kanagawa University of Human Services-led researchers found short-term BMI reductions after an eight-to-12-week ...

Rocket Lab (NASDAQ:RKLB) stock climbed about 30% in one week in December following reports of a planned SpaceX initial public offering in 2026 at a valuation of up to $1.5 trillion. The news renewed ...

A consortium spanning seven European countries has launched the TexMat initiative to develop a deposit-return system for used ...

E3 LITHIUM LTD. (TSXV: ETL) (FSE: OW3) (OTCQX: EEMMF), "E3", "E3 Lithium" or the "Company," a leader in Canadian lithium ...

The KaiNETIC global Phase 3 clinical program includes three global, double-blind, randomized, placebo-controlled Phase 3 trials (KaiNETIC-1, KaiNETIC-2, and KaiNETIC-3) to evaluate weekly ribupatide ...

Elevra Lithium sits between exploration and mature production, offering operating leverage. Read why I rate ELVR stock a Hold ...

The paper, titled, "Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study," was published in Obesity, the peer-reviewed ...